Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
Rudolf A. Baumgartner(Merck & Co., Inc., Rahway, NJ, USA (United States)), Theodore F. Reiss(Merck & Co., Inc., Rahway, NJ, USA (United States)), G. Martínez(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven T. Bird(United States Food and Drug Administration), Matt A. Bernstein(University of London), Robert Angner(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sairia Dass(Merck & Co., Inc., Rahway, NJ, USA (United States)), A. Polis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gabriel Gómez(Costa Rican Department of Social Security), Jonathan M. Edelman(United States Military Academy), Susan Lu(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 61
Related Papers
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
|Nature Communications|2020|539
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
|Scientific Reports|2019|401
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
|Nature Communications|2016|349
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
|Nature Communications|2015|325